Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Communications
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
SurgVision GmbH currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. This workload is distributed across 2 distinct examiners and 2 distinct art units, indicating a diverse spread of examination for a small set of active matters. The prosecution is not concentrated in a single art unit, which may require the applicant to navigate different examiner preferences and internal unit guidelines simultaneously. This decentralized structure suggests that the company's intellectual property covers varied technical aspects within the biotechnology sector, each falling under different administrative oversight at the USPTO.
JAKE MINH VU is identified as the busiest examiner for this portfolio, currently handling 1 pending office action. Because this examiner accounts for half of the total pending actions, their specific examination style and prior history in Biotechnology & Pharmaceuticals will significantly influence the portfolio's immediate progress. Practitioners should monitor the 2 distinct art units to identify any divergent trends in how these biotechnology claims are being evaluated. Success in these matters will likely depend on a tailored approach that addresses the unique requirements of each distinct examiner while maintaining consistency across the 2 pending office actions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VU, JAKE MINH | 1 | 41.1% | +27.2% |
| ELLIOTT, JORDAN MCKENZIE | 1 | 46.9% | +4.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18267590 | PH RESPONSIVE CYANINE DYES AND CONJUGATES THEREOF | VU, JAKE MINH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18267590 | PH RESPONSIVE CYANINE DYES AND CONJUGATES THEREOF | VU, JAKE MINH | — |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| 2666 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18267590 | PH RESPONSIVE CYANINE DYES AND CONJUGATES THEREOF | VU, JAKE MINH | 1618 | §102§103 | Non-Final OA | — | Pending | Jun 15, 2023 |
| 18018161 | PROCESSING OF MULTIPLE LUMINESCENCE IMAGES GLOBALLY FOR THEIR MAPPING AND/OR SEGMENTATION | ELLIOTT, JORDAN MCKENZIE | 2666 | §103 | Non-Final OA | — | Pending | Jan 26, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial